Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Turunen

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Transplantation Proceedings|February 1, 1990
Lymphocytes bind to capillary endothelium during heart allograft rejectionJ P Turunen, J Halttunen, P Häyry, et al.
Scandinavian Journal of Immunology|December 1, 1989
Lymphocyte binding to and penetration through vascular endothelium is stimulated by platelet-activating factorR Renkonen, P Mattila, J P Turunen, et al.
The American Journal of Pathology|September 1, 1990
Characterization of high endothelial-like properties of peritubular capillary endothelium during acute renal allograft rejectionR Renkonen, J P Turunen, J Rapola, et al.
European Journal of Biochemistry|December 1, 1995
Synthesis of a divalent sialyl Lewis x O-glycan, a potent inhibitor of lymphocyte-endothelium adhesion. Evidence that multivalency enhances the saccharide binding to L-selectinH Maaheimo, R Renkonen, J P Turunen, et al.
Transplantation|December 1, 1992
Evidence that lymphocyte traffic into rejecting cardiac allografts is CD11a- and CD49d-dependentJ P Turunen, P Mattila, J Halttunen, et al.
Histopathology|October 8, 2004
Tenascin-C in primary malignant melanoma of the skinS Ilmonen, T Jahkola, J P Turunen, et al.
Pathology Annual|January 1, 1994
Bronchoalveolar lavage. Cytological techniques and interpretation of the cellular profilesE I Taskinen, P S Tukiainen, R L Alitalo, et al.
Melanoma Research|July 17, 1998
Prognostic value of biomarkers in malignant melanomaM Hernberg, J P Turunen, K von Boguslawsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
The CD4+/CD8+ ratio as a prognostic factor in patients with metastatic melanoma receiving chemoimmunotherapyM Hernberg, T Muhonen, J P Turunen, et al.
Glycobiology|January 1, 1996
Synthesis of a tetravalent sialyl Lewis x glycan, a high-affinity inhibitor of L-selectin-mediated lymphocyte binding to endotheliumA Seppo, J P Turunen, L Penttilä, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Transplantation Proceedings|February 1, 1990
Lymphocytes bind to capillary endothelium during heart allograft rejectionJ P Turunen, J Halttunen, P Häyry, et al.
Scandinavian Journal of Immunology|December 1, 1989
Lymphocyte binding to and penetration through vascular endothelium is stimulated by platelet-activating factorR Renkonen, P Mattila, J P Turunen, et al.
The American Journal of Pathology|September 1, 1990
Characterization of high endothelial-like properties of peritubular capillary endothelium during acute renal allograft rejectionR Renkonen, J P Turunen, J Rapola, et al.
European Journal of Biochemistry|December 1, 1995
Synthesis of a divalent sialyl Lewis x O-glycan, a potent inhibitor of lymphocyte-endothelium adhesion. Evidence that multivalency enhances the saccharide binding to L-selectinH Maaheimo, R Renkonen, J P Turunen, et al.
Transplantation|December 1, 1992
Evidence that lymphocyte traffic into rejecting cardiac allografts is CD11a- and CD49d-dependentJ P Turunen, P Mattila, J Halttunen, et al.
Histopathology|October 8, 2004
Tenascin-C in primary malignant melanoma of the skinS Ilmonen, T Jahkola, J P Turunen, et al.
Pathology Annual|January 1, 1994
Bronchoalveolar lavage. Cytological techniques and interpretation of the cellular profilesE I Taskinen, P S Tukiainen, R L Alitalo, et al.
Melanoma Research|July 17, 1998
Prognostic value of biomarkers in malignant melanomaM Hernberg, J P Turunen, K von Boguslawsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
The CD4+/CD8+ ratio as a prognostic factor in patients with metastatic melanoma receiving chemoimmunotherapyM Hernberg, T Muhonen, J P Turunen, et al.
Glycobiology|January 1, 1996
Synthesis of a tetravalent sialyl Lewis x glycan, a high-affinity inhibitor of L-selectin-mediated lymphocyte binding to endotheliumA Seppo, J P Turunen, L Penttilä, et al.
Pageof 3